
Join to View Full Profile
1500 East Medical Center DrUniversity Hospital - Im Nephrology InpatientAnn Arbor, MI 48109
Phone+1 734-888-2871
Dr. Shayman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1985 - 1985
- Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1983 - 1984
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1980 - 1983
- Washington University in St. Louis School of MedicineClass of 1980
Certifications & Licensure
- MI State Medical License 1986 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1994
- Fellow (ASNF) American Society of Nephrology
Publications & Presentations
PubMed
- Degradation of oxidized phospholipids by lysosomal phospholipase A2 regulates pulmonary fibrosis.Doyun Kwak, Song Ling, Natalya Subbotina, James A Shayman, Thomas H Sisson
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2025-06-26 - Hepatic lipid remodeling in cold exposure uncovers direct regulation of bis(monoacylglycero)phosphate lipids by phospholipase A2 group XV.Jessica W Davidson, Raghav Jain, Thomas Kizzar, Gisela Geoghegan, Daniel J Nesbitt
Cell Metabolism. 2025-06-03 - Isomerization of bis(monoacylglycero)phosphate by acyl migration.Akira Abe, Vania Hinkovska-Galcheva, Rakesh Verma, James A Shayman
Journal of Lipid Research. 2025-05-01
Press Mentions
- Protalix’s Phase III Asset for Fabry Could Struggle to Demonstrate Superiority over Fabrazyme but Immunogenicity Benefits Support Regulatory Chances, Experts SayFebruary 5th, 2021
- Sanofi Pivotal Trial to Target Driver of Cyst Growth in PKDNovember 12th, 2018
- Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis from the HALT-PKD TrialsJanuary 4th, 2018
Grant Support
- Lysosomal Phospholipase A2 In Autoimmune DiseaseNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
- The Pharmacological Treatment Of Fabry DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
- The Pharmacologic Treatment Of Fabry DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2008
- Glycosphingolipids In Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
- Glycosphingolipid And Renal CarcinomaNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997
- Sphingolipids And Polycystic Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1997
- Renal Polyol MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1994
- Peptide Hormone Stimulated Inositol MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1989
- Peptide Hormone Stimulated Inositol MetabolismNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: